ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 49 filers reported holding ATYR PHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $105,000 | +1066.7% | 30,115 | +1573.1% | 0.00% | – |
| Q3 2017 | $9,000 | -92.5% | 1,800 | -95.8% | 0.00% | – |
| Q2 2016 | $120,000 | -91.8% | 43,222 | -88.4% | 0.00% | – |
| Q1 2016 | $1,469,000 | -60.2% | 372,850 | -0.8% | 0.00% | -100.0% |
| Q4 2015 | $3,694,000 | -1.1% | 375,750 | +3.2% | 0.00% | 0.0% |
| Q3 2015 | $3,736,000 | +8.3% | 364,173 | +95.5% | 0.00% | 0.0% |
| Q2 2015 | $3,449,000 | – | 186,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $3,930,000 | 4.66% |
| EcoR1 Capital, LLC | 976,986 | $2,101,000 | 0.67% |
| TANG CAPITAL MANAGEMENT LLC | 279,425 | $601,000 | 0.32% |
| Rock Springs Capital Management LP | 475,000 | $1,021,000 | 0.07% |
| Quotient Investors, LLC | 22,200 | $48,000 | 0.03% |
| Alyeska Investment Group, L.P. | 1,072,108 | $2,305,000 | 0.02% |
| TIVERTON ASSET MANAGEMENT LLC | 95,318 | $205,000 | 0.01% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $171,000 | 0.01% |
| Acrospire Investment Management LLC | 12,683 | $27,000 | 0.01% |
| Glen Harbor Capital Management LLC | 179,724 | $386,000 | 0.01% |